$0.930
-0.034 (-3.65%)終値時点
OGI の収益性とマージン
Evaluating the bottom line, Organigram Global Inc maintains a gross margin of 23.06%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at -11.06%, while the net margin is 99.77%. These profitability ratios, combined with a Return on Equity (ROE) of 19.89%, provide a clear picture of how effectively OGI converts its operational activities into shareholder value.
OGI の同業比較
In the context of the broader market, OGI competes directly with industry leaders such as LMNR and GLAS. With a market capitalization of $134.03M, it holds a significant position in the sector. When comparing efficiency, OGI's gross margin of 23.06% stands against LMNR's 12.60% and GLAS's 26.22%. Such benchmarking helps identify whether Organigram Global Inc is trading at a premium or discount relative to its financial performance.
Organigram Global Inc の財務パフォーマンス
OrganiGram's financial performance has been mixed, with a notable recovery in Q3 2026 where net revenue reached $105.8 million, a 49% year-over-year increase, and a gross margin of 23.06%. This indicates a strong rebound from previous declines.
Financials
関連記事
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
本ページは調査目的であり、投資助言ではありません。モデルは誤ることがあります。過去の実績は将来の成果を保証しません。